Cite
APA Citation
Burbage, S., Waters, D., Rossi, C., Kinkead, F., Pilon, D., Muser, E., & Ellis, L. (n.d.). clinical surveillance and PSA outcomes among patients with non-metastatic castration resistant prostate cancer (nmCRPC) treated with a next-generation androgen receptor inhibitor (ARI) in urology clinics with or without in-office dispensing (IOD).. Journal of clinical oncology, 40(28), 410. http://access.bl.uk/ark:/81055/vdc_100169171834.0x00002b